Tumor necrosis factor-α induces renal vasoconstriction as well as natriuresis in mice

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 6, 2008, Pages

  Shahid, Mohd ^a   Francis, Joseph ^b   Majid, Dewan S A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Nitric oxide; Renal hemodynamic; Sodium excretion; Superoxide

Indexed keywords

8 ISOPROSTANE; ARGININE METHYL ESTER; ETANERCEPT; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SODIUM; SUPEROXIDE; TEMPOL;

ARTERIAL PRESSURE; ARTICLE; BLADDER; CANNULA; GLOMERULUS FILTRATION RATE; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY INJURY; MOUSE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; URINALYSIS; VASOCONSTRICTION;

EID: 57349173002     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90297.2008     Document Type: Article

References (55)

1. Banks WA, Moinuddin A, Morley JE. Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice. Neurobiol Aging 22: 671-676, 2001.
2. Bao HF, Zhang ZR, Liang YY, Ma JJ, Eaton DC, Ma HP. Ceramide mediates inhibition of the renal epithelial sodium channel by tumor necrosis factor-α through protein kinase C. Am J Physiol Renal Physiol 293: F1178-F1186, 2007.
3. Baud L, Oudinet JP, Bens M, Noe L, Peraldi MN, Rondeau E, Etienne J, Ardaillou R. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35: 1111-1118, 1989.
4. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin MC, Badoual T, Su JB, Adubeiro S, Roudot-Thoraval F, Dubois-Rande JL, Hittinger L, Pecker F. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation 110: 2003-2009, 2004.
5. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97: 1382-1391, 1998.
6. Braam B, Mitchell KD, Koomans HA, Navar LG. Relevance of the tubuloglomerular feedback mechanism in pathophysiology. J Am Soc Nephrol 4: 1257-1274, 1993.
7. Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahm K, Kelly DJ, Gilbert RE. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury. Hypertension 36: 561-568, 2000.
8. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
9. Chakraborti T, Gosh SK, Michael JR, Batabyl SK, Chakraborti S. Targets of oxidative stress in cardiovascular system. Mol Cell Biochem 187: 1-10, 1998.
10. Chen YF, Li PL, Zou AP. Oxidative stress enhances the production and actions of adenosine in the kidney. Am J Physiol Regul Integr Comp Physiol 281: R1808-R1816, 2001.
11. Chrousos GP. The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann NY Acad Sci 917: 38-67, 2000.
12. Dong X, Swaminathan S, Bachman LA, Croatt AJ, Nath KA, Griffin MD. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int 71: 619-628, 2007.
13. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 294: R76-R83, 2008.
14. Elmarakby AA, Quigley JE, Pollock DM, Imig JD. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47: 557-562, 2006.
15. Féraille E, Doucet A. Sodium-potassium- adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control. Physiol Rev 81: 345-418, 2001.
16. Ferreri NR, Escalante BA, Zhao Y, An SJ, McGiff JC. Angiotensin II induces TNF production by the thick ascending limb: functional implications. Am J Physiol Renal Physiol 274: F148-F155, 1998.
17. Ferreri NR, Zhao Y, Takizawa H, McGiff JC. Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure. J Hypertens 15: 1481-1484, 1997.
18. Francis J, Chu Y, Johnson AK, Weiss RM, Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol 286: H2264-H2271, 2004.
19. Fuentes JM, Talamini MA, Fulton WB, Hanly EJ, Aurora AR, De Maio A. General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock. Clin Vaccine Immunol 13: 281-288, 2006.
20. Gardiner SM, Kemp PA, March JE, Woolley J, Bennett T. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats. Br J Pharmacol 125: 1543-1550, 1998.
21. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD Jr. Renal NF-κB activation and TNF-α upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291: R1817-R1824, 2006.
22. Guggillam A, Hartfield J, Haque M, Francis J. Ang II-induced oxidative stress in the heart is mediated through cytokines (Abstract). FASEB J 388: 16A, 2005.
23. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460, 2007.
24. Haas M, Forbush B 3rd. The Na-K-Cl cotransporter of secretory epithelia. Annu Rev Physiol 62: 515-534, 2000.
25. Hahn AW, Jonas U, Bühler FR, Resink TJ. Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347: 178-180, 1994.
26. Halliwell B, Zhao K, Whiteman M. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic Res 31: 651-69, 1999.
27. Haque MZ, Majid DS. Assessment of renal functional phenotype in mice lacking gp91PHOX subunit of NAD(P)H oxidase. Hypertension 43: 335-40, 2004.
28. Hartfield JN, Haque M, Majid DSA, Francis J. Angiotensin II induced upregulation of myocardial eNOS m RNA is mediated through TNF-alpha (Abstract). FASEB J 20: 722A, 2005.
29. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension 19: 464-474, 1992.
30. Kalra D, Sivasubramanian N, Mann DL. Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway. Circulation 105: 2198-2205, 2002.
31. Kase H, Hashikabe Y, Uchida K, Nakanishi N, Hattori Y. Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress. J Hypertens 23: 1375-1382, 2005.
32. Kopkan L, Majid DS. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension 47: 568-572, 2006.
33. Kopkan L, Majid DS. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Hypertension 46: 1026-1031, 2005.
34. Kopkan L, Castillo A, Francis J, Majid DS. Renal responses to angiotensin II are attenuated in knockout mice lacking the gene for tumor necrosis factor-a (TNF-α). FASEB J 21: 595.20, 2007.
35. - cotransporter in the kidney cortex and medulla. Cytokine 33: 138-144, 2006.
36. Li S, Jiao X, Tao L, Liu H, Cao Y, Lopez BL, Christopher TA, Ma XL. Tumor necrosis factor-α in mechanic trauma plasma mediates cardiomyocyte apoptosis. Am J Physiol Heart Circ Physiol 293: H1847-H1852, 2007.
37. Li S, Tao L, Jiao X, Liu H, Cao Y, Lopez B, Luan RH, Christopher T, Ma XL. TNF-alpha-initiated oxidative/nitrative stress mediates cardiomyocyte apoptosis in traumatic animals. Apoptosis 12: 1795-1802, 2007.
38. Majid DS, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am J Physiol Regul Integr Comp Physiol 287: R27-R32, 2004.
39. Majid DS, Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
40. Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Centorrino T, Siriwardena AK, Cuzzocrea S. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion. Shock 27: 542-551, 2007.
41. Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J. TNF-α-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 293: H2726-H2737, 2007.
42. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
43. Ohashi K, Saigusa T. Sympathetic nervous responses during cytokine-induced fever in conscious rabbits. Pflügers Arch 433: 691-698, 1997.
44. Praticò D, Lawson JA, Rokach J, FitzGerald GA. The isoprostanes in biology and medicine. Trends Endocrinol Metab 12: 243-247, 2001.
45. Romero JC, Reckelhoff JF. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34: 943-949, 1999.
46. Ruiz-Ortega M, Esteban V, Rupérez M, Sánchez- López E, Rodríguez-Vita J, Carvajal G, Egido J. Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15: 159-166, 2006.
47. Scallon B, Cai A, Solowski N, Rosenberg A, Song XY, Shealy D, Wagner C. Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301: 418-426, 2002.
48. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 51: 1345-51, 2008.
49. Taishi P, Churchill L, De A, Obal F Jr, Krueger JM. Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo. Brain Res 1226: 89-98, 2008.
50. Tojo A, Onozato ML, Kobayashi N, Goto A, Matsuoka H, Fujita T. Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat. J Hypertens 23: 165-174, 2005.
51. Vassalli P. The pathophysiology of TNF-alpha. Annu Rev Immunol 10: 411-452, 1992.
52. Yang B, Rizzo V. TNF-α potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: H954-H962, 2007.
53. Yang FL, Li CH, Hsu BG, Tsai NM, Lin SZ, Harn HJ, Chen HI, Liao KW, Lee RP. The reduction of tumor necrosis factor-alpha release and tissue damage by pentobarbital in the experimental endotoxemia model. Shock 28: 309-316, 2007.
54. Yard BA, Daha MR, Kooymans-Couthino M, Bruijn JA, Paape ME, Schrama E, van Es LA, van der Woude FJ. IL-1 alpha stimulated TNF α production by cultured human proximal tubular epithelial cells. Kidney Int 42: 383-389, 1992.
55. Zhang ZH, Wei SG, Francis J, Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF-α in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol 284: R916-R927, 2003.